Jim Cramer says Coca-Cola is a buy after company ‘put on a clinic’ in latest earnings report

Jim Cramer says Coca-Cola is a buy after company ‘put on a clinic’ in latest earnings report


CNBC’s Jim Cramer explained why he believes Coca-Cola is an endurable, investable stock on the heels of its latest quarterly earnings report.

“Coca-Cola put on a clinic, showing you how a seasoned management team can overcome just about any challenge you might throw at them. That’s long-lasting strength. That’s a great stock to put away,” the “Mad Money” host said.

Coca-Cola reported better-than-expected quarterly earnings and revenue on Monday.

Shares of Coke rose 1.06%, notching a new 52-week high earlier in the day.

“The quarter’s a reminder that sometimes you just want to own the best of breed companies in unassailable positions. … It’s not that Coca-Cola’s got no problems — they’re dealing with the same issues as everyone else — it’s that they’ve been able to safely navigate their way through the thicket,” Cramer said.

He attributed Coke’s success to the popular Topo Chico Hard Seltzer, its DoorDash collaboration and other efforts to gain market share and get products to customers.

Coke said it is seeing higher costs for core supplies like high fructose corn syrup and aluminum. But Cramer noted “the good news is that the companies that make cans are finally adding capacity after holding back for a long time, mostly because of Covid.” 

“If we’re going to get out of this inflationary spiral, we either need to see lots of companies adding capacity, or the Federal Reserve will have to crush the economy. When it comes to Coke, obviously its suppliers boosting their production is what really matters,” he said.



Source

How Build-A-Bear went from a penny stock to a retail winner
Business

How Build-A-Bear went from a penny stock to a retail winner

Build-A-Bear Workshop wasn’t always a retail winner. The toy store, known for its interactive experience of building and accessorizing stuffed animals, has gone through a significant turnaround since CEO Sharon Price John took the helm of the company over a decade ago. “When I first came in 2013, that assessment of the brand was strong,” […]

Read More
Inside the dealmaking that pushed Trump to reclassify pot, expand access
Business

Inside the dealmaking that pushed Trump to reclassify pot, expand access

President Donald Trump’s move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way for a Medicare pilot program covering CBD — caps a coordinated, yearlong push by the cannabis industry that combined traditional lobbying, sizable political donations, data-driven messaging and direct outreach to the president’s inner circle, industry […]

Read More
Shoppers are focusing on quality, not deals, in the final days before Christmas
Business

Shoppers are focusing on quality, not deals, in the final days before Christmas

While discounts drive purchasing in the early days of the holiday shopping season, consumers are shifting into more thoughtful, quality gifts in the back half of the season as total spending growth slows. U.S. consumers had spent $187.3 billion so far online between Nov. 1 and Dec. 12, up 6.1% from the same stretch last […]

Read More